CST3 and chronic obstructive pulmonary disease: Consistent with the protease-antiprotease imbalance hypothesis for COPD, we anticipated that COPD patients would have increased plasma levels of cathepsin S along with reduced plasma levels of its cognate inhibitor, cystatin C [5].